Explainable pricing simulations for LibreSign's commercial models.
LibreSign Pricing is an independent engine intended to help evaluate the economic sustainability of LibreSign services. It models alternative offers, compares incremental contribution with full-cost recovery, and makes assumptions and results traceable.
| Model | Purpose |
|---|---|
| LibreSign Cloud | Evaluate standardized, shared hosting and usage assumptions. |
| LibreSign Managed | Evaluate managed capacity, service commitments, and operating costs. |
| LibreSign on customer infrastructure | Evaluate deployment, integration, consulting, and optional ongoing support. |
The engine distinguishes costs that change with additional business from allocations needed to recover the full cost of operations. It also illustrates tax sensitivities and potential cooperative residuals. These are simulation outputs, not automatically approved prices or accounting conclusions.
- Explainability: each result records the applied parameter version and model, formulas, and a reproducible input fingerprint.
- Confidentiality: operational economic parameters belong in private, access-controlled environments, not public source control.
- Separation of responsibilities: WooCommerce remains responsible for existing products, subscriptions, and billing; this engine does not provision accounts or issue invoices.
- Approval boundaries: a simulation does not authorize a quote, deployment, contract, price change, or tax treatment.
This repository contains an early technical increment with deliberately fictional test data only. None of the numbers included in its fixtures represent LibreCode internal costs, approved market offers, or current Brazilian tax obligations. The engine refuses to load a catalog implicitly and cannot authorize commercialization.
No customer-facing pricing integration is active. Access to sensitive calculations must remain restricted until roles, confidentiality controls, independently verified economics, and approval workflows have been implemented and reviewed.